Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular effects of platelet-activating factor.

R E Goldstein1, G Z Feuerstein, L M Bradley

  • 1Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.

Lipids
|December 1, 1991
PubMed
Summary

Platelet-activating factor (PAF) causes circulatory collapse by constricting pulmonary vessels, leading to right heart failure. Thromboxane A2 (TxA2) release contributes to these severe hemodynamic effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transmission potential of human schistosomes can be driven by resource competition among snail intermediate hosts.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Ten simple rules for training yourself in an emerging field.

PLoS computational biology·2021
Same author

Red wine consumption, coronary calcification, and long-term clinical evolution.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2018
Same author

Cuspal Flexure and Stress in Restored Teeth Caused by Amalgam Expansion.

Operative dentistry·2018
Same author

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.

Cardiovascular diabetology·2018
Same author

Effect of pre-medication on gastroduodenoscopy in isoflurane-anesthetized cats.

Veterinary anaesthesia and analgesia·2017

Area of Science:

  • Cardiovascular Physiology
  • Pulmonary Circulation
  • Pharmacology

Background:

  • Sudden release of platelet-activating factor (PAF) can lead to hypotension, tachycardia, and circulatory collapse.
  • Understanding the cardiovascular response to PAF is crucial for managing related emergencies.

Purpose of the Study:

  • To investigate the cardiovascular effects of platelet-activating factor (PAF) administration in young domestic pigs and newborn piglets.
  • To elucidate the mechanisms underlying PAF-induced circulatory dysfunction, particularly pulmonary vascular constriction and right ventricular failure.
  • To examine the role of thromboxane A2 (TxA2) in mediating PAF's adverse hemodynamic effects.

Main Methods:

  • Detailed cardiovascular function studies were performed after PAF administration in pigs and piglets.

Related Experiment Videos

  • Investigated the effects of PAF agonists and antagonists, including TxA2 synthesis inhibitors (OKY-046, indomethacin) and a TxA2 receptor blocker (SQ 29,548).
  • Assessed sustained pulmonary vasoconstriction in response to PAF infusions in anesthetized piglets.
  • Main Results:

    • PAF administration resulted in severe constriction of pulmonary resistance vessels, leading to acute right ventricular failure.
    • Left ventricular dysfunction was primarily attributed to systemic arterial hypotension and reduced ventricular filling.
    • PAF-induced effects were associated with significant thromboxane A2 (TxA2) release and were mimicked by a TxA2 agonist.
    • TxA2 synthesis inhibitors and receptor blockers partially or potently inhibited PAF's adverse actions.

    Conclusions:

    • Severe pulmonary vascular constriction and hemodynamic collapse following intravenous PAF are, at least partially, mediated by PAF-induced TxA2 release.
    • The study indicates that thromboxane A2 plays a significant role in the pathophysiology of PAF-induced circulatory shock.
    • Pulmonary vessels in newborn piglets did not exhibit tachyphylaxis to sustained PAF-induced vasoconstriction.